Focus: Allurion Technologies is a medical device company specializing in gastric balloon systems for obesity management, headquartered in Natick, MA since 2009. The company focuses on minimally invasive metabolic disease solutions with a portfolio of intragastric balloon devices and digital behavior change interventions.
Profile data last refreshed 5h ago · AI intelligence enriched 3d ago
Allurion is a niche medical device play in an attractive market, but minimal hiring and opaque financials make it a higher-risk career move unless you're seeking deep device specialization or early-stage company exposure.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Allurion Technologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Allurion Technologies's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo